VI. Adverse Events and Success of ERCP
Adverse outcomes of ERCPā˜†

https://doi.org/10.1016/S0016-5107(02)70025-4Get rights and content

Section snippets

Definitions of complications, adverse events, unplanned events and other negative outcomes

Consensus definitions for complications of sphincterotomy have been widely adopted since they were introduced in 1991 (Table 2).10

. Consensus definitions for the major complications of ERCP10

Empty CellMildModerateSevere
PancreatitisClinical pancreatitis, amylase at least 3 times normal at more than 24 h after procedure, requiring admission or prolongation of planned admission to 2-3 dPancreatitis requiring hospitalization of 4-10 dHospitalization for more than 10 d, pseudocyst, or intervention (percutaneous

Variations in complication rates

Reported short-term complication rates vary widely. For example, reported rates of pancreatitis after diagnostic ERCP have been reported to vary from 0.74%22 to 5.2%.23 Reasons for such variation include (1) definitions used, for example, changing the threshold of amylase required to define pancreatitis10; (2) thoroughness of detection: prospective studies detect significantly more events than retrospective studies24; (3) patient-related factors: case mix often varies widely between centers;

Risk-factor analyses

Studies that use univariate analysis to identify risk factors for complications may produce misleading results because of inability to sort out confounding variables.25, 26, 27, 28, 29, 30 Recent studies have used multivariate analysis as a tool to identify and quantify the effect of multiple potentially confounding risk factors. However, even these studies may have important limitations because failure to evaluate important variables may allow surrogate or closely linked markers to appear as

Overall complications of ERCP and sphincterotomy

Short-term complications are reported to occur after 5% to 10% of ERCPs with or without sphincterotomy.10, 11, 22, 23, 24, 25, 26, 27, 28, 29, 30, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48 Risk factors for overall and individual complications of ERCP and sphincterotomy are shown in Table 3, Table 4, Table 5. There is a particularly high rate of complications for sphincter of Oddi dysfunction and a relatively low complication rate for bile duct stone extraction.38

Pancreatitis

Rates of pancreatitis after ERCP and sphincterotomy range from less than 1% to 40%, but rates of 5% or more are typical.10, 11, 22, 23, 24, 25, 26, 27, 28, 29, 30, 32, 33, 34, 35, 36, 37, 38, 39, 40, 42, 43, 44, 46, 47 There are many potential mechanisms of injury to the pancreas during ERCP and endoscopic sphincterotomy: mechanical, chemical, hydrostatic, enzymatic, microbiologic, and thermal, although the relative contribution of these mechanisms to post-ERCP pancreatitis is not known.23

Hemorrhage

Hemorrhage occurs primarily after sphincterotomy, with an incidence that varies widely depending on definitions, detection of delayed bleeding, patient factors, and endoscopic technique. Endoscopically observed bleeding is seen in about 10 to 30 percent of sphincterotomies, but does not by itself represent an adverse outcome to the patient.10, 38, 86 Clinically significant hemorrhage including melena or hematemesis or requiring intervention such as endoscopy or blood transfusion is much less

Perforation

Perforation may be retroperitoneal because of extension of a sphincterotomy incision beyond the intramural portion of the bile or pancreatic duct, intraperitoneal as a result of perforation of the bowel wall by the endoscope, or occur at any location because of extramural passage or migration of guidewires or stents. Perforation is now reported in less than 1% of ERCP and sphincterotomies.10, 11, 22, 23, 24, 25, 26, 27, 28, 29, 30, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47,

Cholangitis and cholecystitis

Cholangitis (bile duct infection) and cholecystitis (gallbladder infection) are potential complications or sequelae of ERCP and/or sphincterotomy.10 Risk factors for cholangitis after ERCP and sphincterotomy consist primarily of failed or incomplete biliary drainage45 and use of combined percutaneous-endoscopic procedures.38 Several studies have shown that prophylactic antibiotics can reduce the rate of bacteremia, but few studies have shown a reduction in clinical sepsis after ERCP, and a

Precut sphincterotomy

The use of precut sphincterotomy to gain bile duct access during ERCP is controversial. Principle techniques include needle-knife by the freehand technique58 with or without placement of a pancreatic stent64 (Table 3, Table 4), and the Erlangen pull-type papillotome technique.60 Some experts avoid precutting almost entirely whereas others use precutting for as many as 40% of all sphincterotomies and even for diagnostic ERCP. Complication rates of precut sphincterotomy have been reported to vary

Long-term complications/sequelae

Long-term sequelae of endoscopic biliary and pancreatic sphincterotomy and stent placement include recurrent stone formation, possibly resulting from sphincterotomy stenosis, or bacteriobilia caused by duodenal-biliary reflux, or ā€œsine-materiaā€ cholangitis.12, 13, 14, 96 Recurrent stones and other biliary problems have been reported to occur from 6% to 24% of patients undergoing long-term follow-up after biliary sphincterotomy.12, 13, 14 Recurrent pancreatitis, presumably because of thermal

Training, experience, and ERCP outcomes

The effect of endoscopic training and expertise on outcomes of ERCP is profound, but is difficult to quantify as case mix, therapeutic intent, and technical success rates vary widely. It has been shown that in excess of 200 ERCPs are required for trainees to achieve a minimum goal of 80% success rates at selective biliary cannulation.99, 100 There are few data on the effect of training on complication rates. In accordance, the American Society for Gastrointestinal Endoscopy has recently raised

First page preview

First page preview
Click to open first page preview

References (103)

  • S Sherman et al.

    Complications of endoscopic sphincterotomy: a prospective series with emphasis on the increased risk associated with sphincter of Oddi dysfunction and non dilated bile ducts

    Gastroenterology

    (1991)
  • GK Johnson et al.

    Evaluation of post-ERCP pancreatitis: potential causes noted during controlled study of differing contrast media

    Gastrointest Endosc

    (1997)
  • D Vaira et al.

    Endoscopic sphincterotomy in 1000 consecutive patients

    Lancet

    (1989)
  • ML Freeman et al.

    Risk factors for post-ERCP pancreatitis: a prospective, multicenter study

    Gastrointest Endosc

    (2001)
  • EC Lai et al.

    Urgent biliary decompression after endoscopic retrograde cholangiopancreatography

    Am J Surg

    (1989)
  • ME Maldonado et al.

    Incidence of pancreatitis in patients undergoing sphincter of Oddi manometry (SOM)

    Am J Gastroenterol

    (1999)
  • E Masci et al.

    Complications of diagnostic and therapeutic ERCP: a prospective multicenter study

    Am J Gastroenterol

    (2001)
  • S Motte et al.

    Risk factors for septicemia following endoscopic biliary stenting

    Gastroenterology

    (1991)
  • RA. Kozarek

    Biliary dyskinesia: Are we any closer to defining the entity?

    Gastrointest Endosc Clin N Am

    (1993)
  • WJ. Hogan

    Stenting the pancreas: is this the solution to post-ERCP pancreatitis?

    Gastroenterology

    (1998)
  • S Sherman et al.

    Sphincter of Oddi manometry: decreased risk of clinical pancreatitis with use of a modified aspirating catheter

    Gastrointest Endosc

    (1990)
  • ML. Freeman

    Precut (access) sphincterotomy

    Tech Gastrointest Endosc

    (1999)
  • PB. Cotton

    Precut papillotomy: a risky technique for experts only

    Gastrointest Endosc

    (1989)
  • K Huibregtse et al.

    Precut papillotomy via fine needle-knife papillotome: a safe and effective technique

    Gastrointest Endosc

    (1986)
  • KF Binmoeller et al.

    Papillary roof incision using the Erlangen-type pre-cut papillotome to achieve bile duct cannulation

    Gastrointest Endosc

    (1996)
  • PG. Foutch

    A prospective assessment of results for needle-knife papillotomy and standard endoscopic sphincterotomy

    Gastrointest Endosc

    (1995)
  • FE Kasmin et al.

    Needle-knife sphincterotomy in a tertiary referral center: efficacy and complications

    Gastrointest Endosc

    (1996)
  • S Sherman et al.

    Does leaving a main pancreatic duct stent in place reduce the incidence of precut biliary sphincterotomy (ES)-induced pancreatitis? A final analysis of a randomized prospective study

    Gastrointest Endosc

    (1996)
  • P Tarnasky et al.

    Pancreatic stenting prevents pancreatitis after biliary sphincterotomy in patients with sphincter of Oddi dysfunction

    Gastroenterology

    (1998)
  • T Aizawa et al.

    Stent placement in the pancreatic duct prevents pancreatitis after endoscopic sphincter dilation for removal of bile duct stones

    Gastrointest Endosc

    (2001)
  • A Smithline et al.

    Effect of prophylactic main pancreatic duct stenting on the incidence of biliary endoscopic sphincterotomy-induced pancreatitis in high-risk patients

    Gastrointest Endosc

    (1993)
  • RA. Kozarek

    Pancreatic stents can induce ductal changes consistent with chronic pancreatitis

    Gastrointest Endosc

    (1990)
  • MT Smith et al.

    Alternations in pancreatic ductal morphology following polyethylene pancreatic stent therapy

    Gastrointest Endosc

    (1996)
  • JJ Bergman et al.

    Randomised trial of endoscopic balloon dilation versus endoscopic sphincterotomy for removal of bile duct stones

    Lancet

    (1997)
  • JA DiSario et al.

    Endoscopic balloon dilation compared to sphincterotomy (EDES) for extraction of bile duct stones: preliminary results

    Gastrointest Endosc

    (1997)
  • GA Cortas et al.

    Selective cannulation of the common bile duct: a prospective randomized trial comparing standard catheters with sphincterotomes

    Gastrointest Endosc

    (1999)
  • GH Elta et al.

    Pure cut electrocautery current for sphincterotomy causes less post-procedure pancreatitis than blended current

    Gastrointest Endosc

    (1998)
  • A Andriulli et al.

    Pharmacologic treatment can prevent pancreatic injury after ERCP: a meta-analysis

    Gastrointest Endosc

    (2000)
  • J Deviere et al.

    Interleukin 10 reduces the incidence of pancreatitis after therapeutic endoscopic retrograde cholangiopancreatography

    Gastroenterology

    (2001)
  • GK Johnson et al.

    A comparison of nonionic versus ionic contrast media: results of a prospective, multicenter study

    Gastrointest Endosc

    (1995)
  • AV Sahai et al.

    Nonendoscopic retrograde cholangiopancreatography diagnosis of bile duct stones

    Tech Gastrointest Endosc

    (1999)
  • ML Freeman et al.

    Same-day discharge after endoscopic biliary sphincterotomy: observations from a prospective multicenter complications study

    Gastrointest Endosc

    (1999)
  • JWC Leung et al.

    Endoscopic sphincterotomy-induced hemorrhage: a study of risk factors and the role of epinephrine injection

    Gastrointest Endosc

    (1995)
  • MF Catalano et al.

    Endoscopic sphincterotomy in patients at high risk for gastrointestinal (GI) hemorrhage: a new technique

    Gastrointest Endosc

    (1995)
  • S Sherman et al.

    Endoscopic sphincterotomy-induced hemorrhage: treatment with multipolar electrocoagulation

    Gastrointest Endosc

    (1992)
  • SE. Silvis

    Endoscopic sphincterotomy with an intact gallbladder

    Gastrointest Endosc Clin N Am

    (1991)
  • T Shakoor et al.

    Pre-cut papillotomy

    Gastrointest Endosc

    (1992)
  • PB. Cotton

    Is your sphincterotomy really safeā€”and necessary?

    Gastrointest Endosc

    (1996)
  • JE Geenen et al.

    Endoscopic sphincterotomy: follow-up evaluation of effects on the sphincter of Oddi

    Gastroenterology

    (1984)
  • JL Watkins et al.

    Assessment of technical competence during ERCP training

    Gastrointest Endosc

    (1996)
  • Cited by (0)

    ā˜†

    Reprint requests: Martin L. Freeman, MD, Associate Professor of Medicine, University of Minnesota, Division of Gastroenterology, Hennepin County Medical Center, 701 Park Ave. South, Minneapolis, MN 55415.

    View full text